Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.94
↑ 65% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-11.35
Historical baseline
PeriodValueYoY Change
2025-3.94+41.1%
2024-6.69-15.4%
2023-5.80-26.6%
2022-4.58+63.5%
2021-12.56+72.2%
2020-45.15-652.4%
2019-6.00+45.2%
2018-10.95-68.1%
2017-6.52+42.4%
2016-11.32-